New Cryptocurrency Looking to Appeal to the Masses
Divi Coins wants to make their cryptocurrency as convenient and accessible as possible. The Divi Project is a new crypto company that closed their initial coin sale in November. The new crypto is looking to replace exchanges like Paypal or Venmo.
Geoff McCabe is the Co-founder and CEO at The Divi Project Tim Sanders is the CMO at The Divi Project. The pair joined Cheddar to explain why they think their new cryptocurrency will lead the market. Sanders stresses that as a company, Divi is attentive and responsive to their consumers' needs.
McCabe believes that in the future all cryptocurrencies will be interchangeable and exchanged via digital wallets. So for Divi, the key is to be adopted and trusted by as many people as possible. In terms of future steps, The Divi Project is looking to build out their own blockchain and wallet.
Thinking about trying a new diet but not sure which way to go? An evidence-based analysis of 10 popular eating patterns shows some promote heart health much better than others.
Camilla Marcus, founder of West-Bourne, joined Cheddar News to highlight the issue of wastefulness in the food industry and spoke on the importance of regenerative farming amid a growing climate crisis.
Melissa Whitely, personal trainer for Life Time Fitness, spoke with Cheddar News about the importance of recovery following a tense workout session. "If we're not going through the proper recovery methods, we can have undue pain, discomfort, tightness in our muscles and all those other things we can avoid," she said.
Dr. Payel Gupta, medical director of allergy, asthma, immunology & ENT for LifeMD.com, joined Cheddar News to discuss some tips on how to cope with allergy season. "With the warmer temperatures, we're seeing that the seasons arrive sooner and actually last longer, and also the elevated CO2 levels actually cause the plants to release more pollen," she said.
A new survey from the National Council for Mental Wellbeing shows that four in five behavioral health workers were concerned that labor shortages in their field “negatively impact society as a whole.”
Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it truly helps patients.